NASDAQ:XNCR Xencor Q1 2026 Earnings Report $23.80 -0.08 (-0.34%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$23.80 0.00 (-0.02%) As of 09/25/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Xencor EPS ResultsActual EPS-$1.71Consensus EPS -$0.75Beat/MissMissed by -$0.96One Year Ago EPS-$0.66Xencor Revenue ResultsActual Revenue$4.52 millionExpected Revenue$27.86 millionBeat/MissMissed by -$23.34 millionYoY Revenue Growth-86.20%Xencor Announcement DetailsQuarterQ1 2026Date5/6/2026TimeBefore Market OpensConference Call DateWednesday, May 6, 2026Conference Call Time4:00PM ETUpcoming EarningsXencor's Q3 2026 earnings is estimated for Wednesday, November 4, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 6, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Xencor Earnings HeadlinesXencor, Inc. (NASDAQ:XNCR) Stock Has Average Price Target of $31.12 According to BrokeragesSeptember 26 at 2:28 AM | americanbankingnews.comXencor's XmAb819 Data Could Support Registrational Path, Wedbush SaysSeptember 25 at 5:32 PM | finance.yahoo.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow. | Base Camp Trading (Ad)Xencor (NASDAQ:XNCR) Stock Price Expected to Rise, Bank of America Analyst SaysSeptember 23, 2026 | americanbankingnews.comBofA Adjusts Price Target on Xencor to $26 From $20, Keeps Neutral RatingSeptember 21, 2026 | marketscreener.comMContrasting Xencor (NASDAQ:XNCR) & Anika Therapeutics (NASDAQ:ANIK)September 20, 2026 | americanbankingnews.comSee More Xencor Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Xencor? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xencor and other key companies, straight to your email. Email Address About XencorXencor (NASDAQ:XNCR) is a clinical-stage biopharmaceutical company that develops engineered antibodies and cytokine therapeutics for the treatment of cancer, autoimmune diseases and other serious medical conditions. The company’s platform is designed to modify antibody properties, including immune-system activation, half-life and biological activity, to create differentiated therapeutic candidates. Xencor’s proprietary XmAb technology supports its internal research programs and collaborations with other biopharmaceutical companies. Its pipeline has included investigational medicines targeting immune and cancer-related pathways, including bispecific antibodies and cytokine-based therapies. The company has also licensed its antibody-engineering technology to external partners, contributing to the development of therapies based on XmAb designs. Founded in 1997 and headquartered in Monrovia, California, Xencor serves global pharmaceutical and biotechnology markets through its research programs, licensing arrangements and strategic collaborations. The company’s leadership includes co-founder Bassil I. Dahiyat, who has served as president and chief executive officer and guides the company’s scientific and corporate development activities.View Xencor ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/25Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin SettlementSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
